Bausch Health Companies (BHC) Change in Cash (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Change in Cash came in at $526.0 million in Q2 2026, down 10.24% year-over-year from $586.0 million in Q2 2025, and up 4146.15% quarter-over-quarter from -$13.0 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Change in Cash (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Change in Cash across 18 years of filings, most recently posting $526.0 million for Q2 2026.
- In Q2 2026, Change in Cash fell 10.24% year-over-year to $526.0 million; the TTM figure through Jun 2026 stood at $95.0 million (down 91.52% YoY), while the FY2025 annual figure was $124.0 million, down 48.12% from the prior year.
- Change in Cash came in at $526.0 million for Q2 2026 at Bausch Health Companies, up from -$13.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $586.0 million in Q2 2025 to a low of -$1.4 billion in Q3 2022.
- Average Change in Cash over 5 years is -$15.6 million, with a median of $22.0 million recorded in 2023.
- Year-over-year, Change in Cash slumped 9771.43% in 2022 and jumped 543.94% in 2025.
- Over 5 years, Change in Cash stood at $94.0 million in 2022, then surged by 93.62% to $182.0 million in 2023, then surged by 147.8% to $451.0 million in 2024, then sank by 103.33% to -$15.0 million in 2025, then soared by 3606.67% to $526.0 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were $526.0 million in Q2 2026, -$13.0 million in Q1 2026, and -$15.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -86.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -915.70 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -44.45 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -64.79 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 526.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 279.95 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 49.04 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 52.68 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 526.00 Mn |
| Mar 31, 2026 | -13.00 Mn |
| Dec 31, 2025 | -15.00 Mn |
| Sep 30, 2025 | -403.00 Mn |
| Jun 30, 2025 | 586.00 Mn |
| Mar 31, 2025 | -44.00 Mn |
| Dec 31, 2024 | 451.00 Mn |
| Sep 30, 2024 | 127.00 Mn |
| Jun 30, 2024 | -132.00 Mn |
| Mar 31, 2024 | -207.00 Mn |
| Dec 31, 2023 | 182.00 Mn |
| Sep 30, 2023 | 192.00 Mn |
| Jun 30, 2023 | 57.00 Mn |
| Mar 31, 2023 | -60.00 Mn |
| Dec 31, 2022 | 94.00 Mn |
| Sep 30, 2022 | -1.38 Bn |
| Jun 30, 2022 | -581.00 Mn |
| Mar 31, 2022 | 341.00 Mn |
| Dec 31, 2021 | 215.00 Mn |
| Sep 30, 2021 | -14.00 Mn |